GlassScriptPhysician profile
Amit K Reddy
NPI 1457714081
$4,240.47
in general payments reported to CMS, 2019-2025
9 companies · $93.64 in 2025
The $93.64 reported for 2025 was less than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $34.45 · 2022: $3,323 · 2023: $277 · 2024: $513 · 2025: $93.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $883.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyepoint US, INC. | $3,382.15 | 2021-2023 | |
| Boston Scientific Corporation | $241.78 | 2023-2024 | Rezum Generator, Lithovue |
| Bausch & Lomb Americas INC. | $219.63 | 2023-2024 | Xipere |
| Alimera Sciences, INC. | $193.06 | 2024 | Yutiq, Iluvien |
| Ani Pharmaceuticals, INC. | $58.84 | 2025 | Iluvien |
| Ethicon US, LLC | $57.26 | 2024-2025 | Echelon Flex, Ethicon, Stratafix |
| Astellas Pharma US INC | $50.56 | 2024 | Xtandi |
| Amgen INC. | $24.07 | 2023 | Avsola, Amjevita |
| Genentech, INC. | $13.12 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.